Literature DB >> 2575869

Mediterranean spotted fever in Salamanca, Spain. Epidemiological study in patients and serosurvey in animals and healthy human population.

J I Herrero-Herrero1, R Ruiz-Beltrán, A M Martín-Sánchez, E J García.   

Abstract

Mediterranean spotted fever is a spotted fever group rickettsiosis caused by Rickettsia conorii. The fever has a recognized incidence in large geographic areas, and its presence in Salamanca Province (Spain) has been well documented since 1981. This work presents the results of the centralized prospective survey carried out in this area and was designed to study the epidemiological behavior of the disease and the prevalence of antibodies against R. conorii among animals and healthy human population. In 110 patients with confirmed diagnosis by an immunofluorescent antibody test we have observed a bimodal temporal curve of incidence of Mediterranean spotted fever in our zone and their predominant origin in villages under 2000 inhabitants. The serosurvey in a statistically representative sample of the human population of Salamanca shows a rate of 73.5% of reactive sera and percentages as high as 82% in samples from small villages. The seroepidemiological study of 300 animals reveals a widespread response to rickettsial antigens throughout the province. Immunofluorescent antibody titers of greater than or equal to 1:40 are present in 93% of dogs and high rates and titers are detected in other domestic mammals, suggesting their feasible epidemiological role in Mediterranean spotted fever.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575869     DOI: 10.1016/0001-706x(89)90046-6

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  21 in total

1.  Prevalence of antibodies to spotted fever group rickettsiae in the region of Split (southern Croatia).

Authors:  Volga Punda-Polić; Zorana Klismanić; Vesna Capkun
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

2.  Use of western blot to analyze the reactivity of sera from patients with Mediterranean spotted fever.

Authors:  J I Herrero-Herrero; D H Walker; R Ruiz-Beltrán
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-10       Impact factor: 3.267

3.  Mediterranean spotted fever in Marseille: descriptive epidemiology and the influence of climatic factors.

Authors:  D Raoult; H Tissot Dupont; P Caraco; P Brouqui; M Drancourt; C Charrel
Journal:  Eur J Epidemiol       Date:  1992-03       Impact factor: 8.082

4.  Mediterranean spotted fever: a preliminary tick field study.

Authors:  J A Oteo; A Estrada-Peña; C Ortega-Pérez; V Martínez de Artola
Journal:  Eur J Epidemiol       Date:  1996-10       Impact factor: 8.082

5.  Molecular and serological study of rickettsial infection in humans, and in wild and farm animals, in the province of Burgos, Spain.

Authors:  Lourdes Lledó; Gerardo Domínguez-Peñafiel; Consuelo Giménez-Pardo; Isabel Gegúndez; Rosario González; José Vicente Saz
Journal:  Vector Borne Zoonotic Dis       Date:  2014-05-27       Impact factor: 2.133

6.  Antibodies to Rickettsia conorii in dogs: seasonal differences.

Authors:  E Espejo; M D Alegre; B Font; A Font; F Segura; F Bella
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

7.  Spotted fever group Rickettsia in brown dog ticks Rhipicephalus sanguineus in southwestern Spain.

Authors:  F J Márquez; J J Rodríguez-Liébana; R C Soriguer; M A Muniaín; M Bernabeu-Wittel; A Caruz; F Contreras-Chova
Journal:  Parasitol Res       Date:  2008-06       Impact factor: 2.289

8.  Spotted fever group Rickettsia in ticks from southeastern Spain natural parks.

Authors:  Francisco J Márquez
Journal:  Exp Appl Acarol       Date:  2008-08-02       Impact factor: 2.132

Review 9.  Ecological questions concerning rickettsiae.

Authors:  J Rehácek; I V Tarasevich
Journal:  Eur J Epidemiol       Date:  1991-05       Impact factor: 8.082

10.  Questions on Mediterranean spotted fever a century after its discovery.

Authors:  Clarisse Rovery; Philippe Brouqui; Didier Raoult
Journal:  Emerg Infect Dis       Date:  2008-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.